Alembic Pharmaceuticals Limited (APLLTD NSE) stock market data APIs
INR914.2098
46.77(5.1%)
as of November 6, 2025
Try our APIs with
free plan!
Alembic Pharmaceuticals Limited Financial Data Overview
Price chart is built with
Anychart
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Prev. Close
914.2098
Open
960.9767
High
960.9767
Low
898.5947
52 wk Range
717.226-1111.5915
Market Cap
186 735 M
P/E Ratio
29.43
Shares Outstanding
197 M
Revenue
70 778 M
EPS
9.4
Dividends (Yield)
0
Beta
0.428
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Alembic Pharmaceuticals Limited (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Alembic Pharmaceuticals Limited data using free add-ons & libraries
Get Alembic Pharmaceuticals Limited Fundamental Data
Alembic Pharmaceuticals Limited Fundamental data includes:
- Net Revenue: 70 778 M
- EBITDA: 11 046 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: 8.7
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Alembic Pharmaceuticals Limited News
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
